Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats

Context: Epilepsy is a common life-threatening neurological disorder that is often drug-resistant and associated with cognitive impairment. The traditional Chinese patent medicine Songling Xuemaikang capsules (SXC) is clinically used for epilepsy therapy and alleviation of cognitive impairment. Obje...

Full description

Bibliographic Details
Main Authors: Haiyan Yang, Rui Zhang, Chen Jia, Mengyu Chen, Wen Yin, Liming Wei, Haisheng Jiao
Format: Article
Language:English
Published: Taylor & Francis Group 2019-01-01
Series:Pharmaceutical Biology
Subjects:
Online Access:http://dx.doi.org/10.1080/13880209.2018.1563619
id doaj-d38e4e203b2b4d3a9bf71cf40d3cd8fc
record_format Article
spelling doaj-d38e4e203b2b4d3a9bf71cf40d3cd8fc2020-11-25T03:07:48ZengTaylor & Francis GroupPharmaceutical Biology1388-02091744-51162019-01-01571212710.1080/13880209.2018.15636191563619Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled ratsHaiyan Yang0Rui Zhang1Chen Jia2Mengyu Chen3Wen Yin4Liming Wei5Haisheng Jiao6Lanzhou University Second HospitalLanzhou UniversityLanzhou University Second HospitalLanzhou UniversityLanzhou University Second HospitalLanzhou University Second HospitalLanzhou University Second HospitalContext: Epilepsy is a common life-threatening neurological disorder that is often drug-resistant and associated with cognitive impairment. The traditional Chinese patent medicine Songling Xuemaikang capsules (SXC) is clinically used for epilepsy therapy and alleviation of cognitive impairment. Objective: This study investigates the neuronal protective effect of SXC combined with carbamazepine (CBZ) on epilepsy and cognitive impairment in kainic acid-kindled SD rats. Materials and methods: Kainic acid-kindled rats were established by injection of 0.45 μg kainic acid and randomly divided into 5 groups (n = 14): saline (sham-operated), control, CBZ, SXC and CBZ + SXC combined group. Rats in the treatment groups received CBZ (50 mg/kg/d), SXC (600 mg/kg/d) or combined CBZ (50 mg/kg/d) + SXC (600 mg/kg/d) via intragastric injection for 60 days. Epileptic behaviours, cognitive impairment, neuronal apoptosis and expression of p-Akt, Akt and caspase-9 were measured, and the alleviation of cognitive damage and neuronal apoptosis was analyzed. Results: The combined administration of SXC and CBZ significantly decreased the frequency of seizures (1.2 ± 0.3) and the number of episodes (1.3 ± 0.5) above stage III (p < 0.05). Neuronal apoptosis was improved (p < 0.01), and cognitive damage was ameliorated (p < 0.05).The level of p-Akt was enhanced (p < 0.01) whereas the expression of caspase-9 was evidently inhibited (p < 0.01) in the combined group. Conclusions: The present findings confirm that the combined use of SXC with CBZ can effectively control epileptic seizures, alleviate damage to hippocampal neurons and protect against cognitive impairment. The mechanism of action might be related to the upregulation of p-Akt and inhibition of caspase-9 expression.http://dx.doi.org/10.1080/13880209.2018.1563619cognitive impairmentneuron apoptosisp-aktcaspase-9
collection DOAJ
language English
format Article
sources DOAJ
author Haiyan Yang
Rui Zhang
Chen Jia
Mengyu Chen
Wen Yin
Liming Wei
Haisheng Jiao
spellingShingle Haiyan Yang
Rui Zhang
Chen Jia
Mengyu Chen
Wen Yin
Liming Wei
Haisheng Jiao
Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats
Pharmaceutical Biology
cognitive impairment
neuron apoptosis
p-akt
caspase-9
author_facet Haiyan Yang
Rui Zhang
Chen Jia
Mengyu Chen
Wen Yin
Liming Wei
Haisheng Jiao
author_sort Haiyan Yang
title Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats
title_short Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats
title_full Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats
title_fullStr Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats
title_full_unstemmed Neuronal protective effect of Songling Xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats
title_sort neuronal protective effect of songling xuemaikang capsules alone and in combination with carbamazepine on epilepsy in kainic acid-kindled rats
publisher Taylor & Francis Group
series Pharmaceutical Biology
issn 1388-0209
1744-5116
publishDate 2019-01-01
description Context: Epilepsy is a common life-threatening neurological disorder that is often drug-resistant and associated with cognitive impairment. The traditional Chinese patent medicine Songling Xuemaikang capsules (SXC) is clinically used for epilepsy therapy and alleviation of cognitive impairment. Objective: This study investigates the neuronal protective effect of SXC combined with carbamazepine (CBZ) on epilepsy and cognitive impairment in kainic acid-kindled SD rats. Materials and methods: Kainic acid-kindled rats were established by injection of 0.45 μg kainic acid and randomly divided into 5 groups (n = 14): saline (sham-operated), control, CBZ, SXC and CBZ + SXC combined group. Rats in the treatment groups received CBZ (50 mg/kg/d), SXC (600 mg/kg/d) or combined CBZ (50 mg/kg/d) + SXC (600 mg/kg/d) via intragastric injection for 60 days. Epileptic behaviours, cognitive impairment, neuronal apoptosis and expression of p-Akt, Akt and caspase-9 were measured, and the alleviation of cognitive damage and neuronal apoptosis was analyzed. Results: The combined administration of SXC and CBZ significantly decreased the frequency of seizures (1.2 ± 0.3) and the number of episodes (1.3 ± 0.5) above stage III (p < 0.05). Neuronal apoptosis was improved (p < 0.01), and cognitive damage was ameliorated (p < 0.05).The level of p-Akt was enhanced (p < 0.01) whereas the expression of caspase-9 was evidently inhibited (p < 0.01) in the combined group. Conclusions: The present findings confirm that the combined use of SXC with CBZ can effectively control epileptic seizures, alleviate damage to hippocampal neurons and protect against cognitive impairment. The mechanism of action might be related to the upregulation of p-Akt and inhibition of caspase-9 expression.
topic cognitive impairment
neuron apoptosis
p-akt
caspase-9
url http://dx.doi.org/10.1080/13880209.2018.1563619
work_keys_str_mv AT haiyanyang neuronalprotectiveeffectofsonglingxuemaikangcapsulesaloneandincombinationwithcarbamazepineonepilepsyinkainicacidkindledrats
AT ruizhang neuronalprotectiveeffectofsonglingxuemaikangcapsulesaloneandincombinationwithcarbamazepineonepilepsyinkainicacidkindledrats
AT chenjia neuronalprotectiveeffectofsonglingxuemaikangcapsulesaloneandincombinationwithcarbamazepineonepilepsyinkainicacidkindledrats
AT mengyuchen neuronalprotectiveeffectofsonglingxuemaikangcapsulesaloneandincombinationwithcarbamazepineonepilepsyinkainicacidkindledrats
AT wenyin neuronalprotectiveeffectofsonglingxuemaikangcapsulesaloneandincombinationwithcarbamazepineonepilepsyinkainicacidkindledrats
AT limingwei neuronalprotectiveeffectofsonglingxuemaikangcapsulesaloneandincombinationwithcarbamazepineonepilepsyinkainicacidkindledrats
AT haishengjiao neuronalprotectiveeffectofsonglingxuemaikangcapsulesaloneandincombinationwithcarbamazepineonepilepsyinkainicacidkindledrats
_version_ 1715298712167645184